Virios Therapeutics, Inc. (NASDAQ:VIRI) Short Interest Down 33.4% in September

Virios Therapeutics, Inc. (NASDAQ:VIRI – Get Free Report) was the recipient of a significant decline in short interest in the month of September. As of September 30th, there was short interest totalling 278,500 shares, a decline of 33.4% from the September 15th total of 418,400 shares. Based on an average daily volume of 546,700 shares, […]

Related Keywords

Gregory Scott Duncan ,Geode Capital Management ,Virios Therapeutics Inc ,Vanguard Group Inc ,Mccollum Christoferson Group ,Nasdaq ,Renaissance Technologies ,Virios Therapeutics ,Get Free Report ,Scott Duncan ,Collum Christoferson Group ,Capital Management ,Street Corp ,Virios Therapeutics Daily ,Nasdaq Viri ,Loviri ,Medical ,Stocks ,Options ,Put ,Call ,